Aushon expands facility to meet biomarker service demand
The company reports that there has been strong demand for its multiplex immunoassays products and services, which it claims can detect low quantities of proteins, adding that it maintains its belief in the potential of the protein biomarker business.
Consequently a focus of the expansion of the Billerica, Massachusetts, US facility has been doubling multiplex immunoassay manufacturing capacity. The new operations are increasingly automated to improve throughput and reduce variability of a number of production processes.
Furthermore, the expansion and renovation of the headquarters has allowed Aushon to consolidate the operations of the recently acquired Searchlight at the facility.
Peter Honkanen, CEO of Aushon, believes this “allows [the company] to work more efficiently, encourages collaboration and innovation, and takes advantage of the inherent synergies that inspired Aushon to acquire the SearchLight business and technology assets”.
Service offering
From the expanded facility, which houses a BL-2 level laboratory and clean and cold rooms, Aushon will offer a range of products and services for biomarker discovery, development and analysis.
These include a protein biomarker sample testing service that allows researchers to submit samples for quantitative analysis in Searchlight Biomarker arrays. In addition Aushon offers custom microarray printing that it claims offers “unmatched versatility and flexibility”.
This allows Aushon to print virtually any sample on to any substrate, “with unequalled reproducibility, accuracy and rapid turnaround”, according to the company.
Aushon also manufactures a range of products for use by researchers. These include chemiluminescent and Infrared Assay Kits and a microarray printer.
